Vasculitis Treatment and Management: multi-phase immunological suppression, endothelial preservation, and systemic glucocorticoid-sparing protocols

Explore treatment options for Vasculitis at Liv Hospital. Learn how we manage the immune system to reduce inflammation and protect your vital organs.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Treatment and Management

What AreThe Treatments of Vasculitis?

Treating vasculitis means calming the overactive immune system to stop inflammation, while also trying to limit medication side effects. Treatment usually has two phases: induction, which uses strong medicines to quickly control the disease, and maintenance, which uses milder drugs to keep it from returning. At Liv Hospital, treatment is tailored to each patient’s needs and the organs affected.

Icon LIV Hospital

Induction Therapy

image 20 9 LIV Hospital

Corticosteroids

Glucocorticoids, such as prednisone or methylprednisolone, are the first line of defense.

  • Mechanism: They rapidly reduce inflammation by suppressing multiple parts of the immune system.
  • Administration: High doses are often given initially, sometimes intravenously (pulse therapy) for organ-threatening disease, followed by high-dose oral pills.
  • Tapering: Once the disease is controlled, the dose is gradually reduced (tapered) over months to minimize long-term side effects like bone loss, weight gain, and diabetes.

Cyclophosphamide and Rituximab

For severe, life-threatening vasculitides (like kidney or lung involvement in ANCA vasculitis), stronger immunosuppressants are needed alongside steroids.

  • Cyclophosphamide: A potent chemotherapy drug that suppresses the immune system. It is very effective but carries risks of bladder toxicity and infertility.
  • Rituximab: A biological therapy that targets B cells, the immune cells responsible for making antibodies. It has become a preferred alternative to cyclophosphamide for many types of vasculitides due to a better safety profile regarding fertility.
Icon 1 LIV Hospital

Maintenance Therapy

image 21 6 LIV Hospital

Once remission is achieved, typically after 3 to 6 months, the treatment switches to maintenance to prevent relapse.

  • Azathioprine: A commonly used oral immunosuppressant for maintenance.
  • Methotrexate: Used for less severe disease or maintenance, particularly in Giant Cell Arteritis or GPA.
  • Mycophenolate Mofetil: Often used for kidney maintenance.
  • Duration: Maintenance therapy usually lasts for 18 to 24 months, sometimes longer, depending on the risk of relapse.

Biological Therapies

Newer targeted therapies are transforming vasculitis care.

  • Tocilizumab: An IL-6 inhibitor approved for the treatment of Giant Cell Arteritis. It allows for faster steroid tapering.
  • Mepolizumab: An IL-5 inhibitor used specifically for Eosinophilic Granulomatosis with Polyangiitis (EGPA) to control asthma and eosinophilia.
  • TNF Inhibitors: Drugs like infliximab or adalimumab are used for Takayasu arteritis and Behcet’s disease.

Plasma Exchange (Plasmapheresis)

In critical cases, such as rapidly progressing kidney failure or pulmonary hemorrhage, plasma exchange may be used.

  • Procedure: The patient’s blood is passed through a machine that removes the plasma, which contains the harmful antibodies and immune complexes, and replaces it with healthy plasma or albumin.
  • Goal: To temporarily remove the drivers of inflammation while medication takes effect

Surgical and Interventional Treatment

  • Vascular Bypass: In large vessel vasculitides like Takayasu arteritis, if a vessel becomes permanently blocked, bypass surgery may be needed to restore blood flow to a limb or organ.
  • Stenting: Angioplasty and stenting can be performed to open narrowed arteries, typically done when the disease is in a “quiet” or non-inflammatory phase to prevent failure.
  • Sinus Surgery: Patients with GPA may require surgery to open blocked sinuses or repair a saddle nose deformity.
Vasculitis

Managing Comorbidities and Side Effects

Treatment involves more than just fighting the vasculitis; it involves protecting the body from the treatment itself.

  • Infection Prevention: Patients on heavy immunosuppression are prescribed antibiotics (like co-trimoxazole) to prevent specific infections like Pneumocystis pneumonia. Vaccinations (non-live) are crucial.
  • Bone Health: Long-term steroid use weakens bones. Calcium, Vitamin D, and bisphosphonates are prescribed to prevent osteoporosis.
  • Gastric Protection: Proton pump inhibitors are used to prevent stomach ulcers caused by steroids.
  • Cardiovascular Risk: Aggressive management of blood pressure and cholesterol is essential, as inflammation increases heart disease risk.

Lifestyle Adjustments

  • Diet: A heart-healthy diet low in salt is important, especially to control fluid retention and blood pressure while on steroids.
  • Smoking Cessation: Essential for all patients, but absolutely critical for those with Buerger’s disease, where quitting smoking is the only way to stop the disease progression.
  • Exercise: Regular, low-impact exercise helps maintain muscle mass and bone density.

Get an Online Consultation with
Certified Doctors

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Selman Emiroğlu Liv Hospital Ulus Assoc. Prof. MD. Selman Emiroğlu General Surgery Op. MD. Gökçe Aylaz Liv Hospital Ulus Op. MD. Gökçe Aylaz General Surgery Prof. MD. Mehmet Levhi Akın Liv Hospital Ulus Prof. MD. Mehmet Levhi Akın General Surgery Op. MD. Şeyma Karakuş Liv Hospital Vadistanbul Op. MD. Şeyma Karakuş General Surgery Prof. MD. Onur Bayraktar Liv Hospital Vadistanbul Prof. MD. Onur Bayraktar General Surgery Assoc. Prof. MD. Mehmet Tokaç Liv Hospital Bahçeşehir Assoc. Prof. MD. Mehmet Tokaç General Surgery Asst. Prof. MD. Alaaddin Aydın Liv Hospital Bahçeşehir Asst. Prof. MD. Alaaddin Aydın General Surgery Asst. Prof. MD. Musa Diri Liv Hospital Bahçeşehir Asst. Prof. MD. Musa Diri General Surgery Asst. Prof. MD. Tansu Altıntaş Liv Hospital Bahçeşehir Asst. Prof. MD. Tansu Altıntaş General Surgery MD. Eryiğit Eren Liv Hospital Bahçeşehir MD. Eryiğit Eren General Surgery Op. MD. Rıdvan Gökay Liv Hospital Bahçeşehir Op. MD. Rıdvan Gökay General Surgery Prof. MD. Ayhan Dinçkan Liv Hospital Bahçeşehir Prof. MD. Ayhan Dinçkan General Surgery Prof. MD. M.A. Samet Bozkurt Liv Hospital Bahçeşehir Prof. MD. M.A. Samet Bozkurt General Surgery Asst. Prof. MD. Burak Kankaya Liv Hospital Topkapı Asst. Prof. MD. Burak Kankaya General Surgery Liv Hospital Topkapı Asst. Prof. MD. Yusuf Emre Altundal General Surgery Prof. MD. Halil Alış Liv Hospital Topkapı Prof. MD. Halil Alış General Surgery Prof. MD. Selin Kapan Liv Hospital Topkapı Prof. MD. Selin Kapan General Surgery Op. MD. Ahmet Turan Durak Liv Hospital Ankara Op. MD. Ahmet Turan Durak General Surgery Op. MD. Sera Yazıcı Liv Hospital Ankara Op. MD. Sera Yazıcı General Surgery Op. MD. Zafer Şahlı Liv Hospital Ankara Op. MD. Zafer Şahlı General Surgery Prof. MD. Ersin Gürkan Dumlu Liv Hospital Ankara Prof. MD. Ersin Gürkan Dumlu General Surgery Prof. MD. Hatim Yahya Uslu Liv Hospital Ankara Prof. MD. Hatim Yahya Uslu General Surgery Prof. MD. Sait Zafer Ferahköse Liv Hospital Ankara Prof. MD. Sait Zafer Ferahköse General Surgery Op.MD. Ömer Söylemez Liv Hospital Gaziantep Op.MD. Ömer Söylemez General Surgery Prof. MD. İbrahim Yetim Liv Hospital Gaziantep Prof. MD. İbrahim Yetim General Surgery Op. MD. Sultan Ayaz Liv Hospital Samsun Op. MD. Sultan Ayaz General Surgery Op. MD. Yılmaz Karagöz Liv Hospital Samsun Op. MD. Yılmaz Karagöz General Surgery Prof. MD. Recep Aktimur Liv Hospital Samsun Prof. MD. Recep Aktimur General Surgery Prof. MD. Serdar Yol Liv Hospital Samsun Prof. MD. Serdar Yol General Surgery MD.  EMİN BAYRAMOV Liv Bona Dea Hospital Bakü MD. EMİN BAYRAMOV General Surgery MD.  LALE İSMAYILOVA Liv Bona Dea Hospital Bakü MD. LALE İSMAYILOVA General Surgery MD. GÜNAY ALLAHVERDİYEVA Liv Bona Dea Hospital Bakü MD. GÜNAY ALLAHVERDİYEVA General Surgery MD. VÜQAR CEFEROV Liv Bona Dea Hospital Bakü MD. VÜQAR CEFEROV General Surgery Prof. MD. Ahmet Cem Dural Liv Hospital Ulus + Liv Hospital Vadistanbul Prof. MD. Ahmet Cem Dural General Surgery Prof. MD. Koray Acarlı Liv Hospital Ulus + Liv Hospital Vadistanbul Prof. MD. Koray Acarlı General Surgery

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Group 346 LIV Hospital

Reviews from 9,651

4,9

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

FREQUENTLY ASKED QUESTIONS

What is the main drug for vasculitis?
  • Corticosteroids (like prednisone) are the most common initial treatment to quickly stop inflammation.
  • Most patients require treatment for at least 1 to 2 years, but some forms of vasculitis require lifelong therapy to prevent relapse.

Rituximab is a biologic medication that depletes B cells. It is increasingly used as a primary treatment for ANCA-associated vasculitis

Long-term side effects include weight gain, a round face, high blood pressure, diabetes, osteoporosis, and thin skin.

  • Many types can be put into remission where there are no symptoms, but “cure” is a difficult term. Relapse is possible, so long-term monitoring is needed.
Spine Hospital of Louisiana

RELATED VIDEOS

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17

How helpful was it?

helpful
GDPR
helpful
GDPR
helpful
GDPR